C
CTXR
CITIUS PHARMACEU
0.5529
-0.0030-0.54%Pre Market: 0.5529 0.0000 0.00%04:24 06/11 EDT
OPEN/PREV CLOSE0.5736/0.5726
TODAY RANGE0.5400-0.5999
VOL425.95K
MARKET CAP14.82M
52 WEEK RANGE0.4760-2.480
AVG VOL (3M)695.34K
% TURNOVER1.55%
TURNOVER--
P/E (TTM)-0.2083
% RANGE10.46%
EPS(TTM)-2.5926
P/E(FORWARD)-0.2888
P/B0.1963
BVPS2.750
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP14.56M
SHARES OUTSTANDING27.45M
NEXT EARNINGS08/10-08/14
FREE FLOAT26.96M
LOT SIZE1
EX-DATE11/26/2024
News
Press Releases
Financial Reports
Profile
TipRanks·06/01 22:40
Citius Highlights LYMPHIR Combo Data in Gynecologic Cancers
TipRanks·06/01 12:16
Citius Oncology highlights Phase 1 data evaluating Lymphir at ASCO
TipRanks·05/23 09:01
CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
TipRanks·05/22 21:05
Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders
Reuters·05/19 07:56
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
Dow Jones·05/18 15:14
Citius Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy
Dow Jones·05/18 15:14
Citius Pharmaceuticals Price Target Announced at $4.00/Share by HC Wainwright & Co.
TipRanks·05/18 13:00
Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright
Benzinga·05/18 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.